Chugai Pharmaceutical Dividends and Buybacks
Dividend criteria checks 3/6
Chugai Pharmaceutical is a dividend paying company with a current yield of 1.29% that is well covered by earnings.
Key information
1.3%
Dividend yield
-0.002%
Buyback Yield
| Total Shareholder Yield | 1.3% |
| Future Dividend Yield | 1.6% |
| Dividend Growth | 2.6% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | JP¥82.000 |
| Payout ratio | 34% |
Recent dividend and buyback updates
Chugai Pharmaceutical's (TSE:4519) Dividend Will Be ¥41.00
Oct 30
Chugai Pharmaceutical's (TSE:4519) Dividend Will Be ¥41.00
Oct 15Chugai Pharmaceutical's (TSE:4519) Dividend Will Be ¥41.00
Sep 24Chugai Pharmaceutical (TSE:4519) Is Due To Pay A Dividend Of ¥41.00
Jul 27Chugai Pharmaceutical (TSE:4519) Is Increasing Its Dividend To ¥41.00
Jun 19Recent updates
Chugai Pharmaceutical Co., Ltd.'s (TSE:4519) Share Price Could Signal Some Risk
Dec 23Calculating The Fair Value Of Chugai Pharmaceutical Co., Ltd. (TSE:4519)
Dec 05Chugai Pharmaceutical's (TSE:4519) Dividend Will Be ¥41.00
Oct 30Chugai Pharmaceutical Co., Ltd. Just Beat Revenue By 12%: Here's What Analysts Think Will Happen Next
Oct 29Chugai Pharmaceutical's (TSE:4519) Dividend Will Be ¥41.00
Oct 15Should You Be Adding Chugai Pharmaceutical (TSE:4519) To Your Watchlist Today?
Oct 12Chugai Pharmaceutical's (TSE:4519) Dividend Will Be ¥41.00
Sep 24Results: Chugai Pharmaceutical Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates
Jul 30Chugai Pharmaceutical (TSE:4519) Is Due To Pay A Dividend Of ¥41.00
Jul 27Estimating The Intrinsic Value Of Chugai Pharmaceutical Co., Ltd. (TSE:4519)
Jul 15Chugai Pharmaceutical (TSE:4519) Is Increasing Its Dividend To ¥41.00
Jun 19Chugai Pharmaceutical Co., Ltd.'s (TSE:4519) Business Is Trailing The Market But Its Shares Aren't
Jun 17Chugai Pharmaceutical (TSE:4519) Is Paying Out A Larger Dividend Than Last Year
May 04We Think That There Are Some Issues For Chugai Pharmaceutical (TSE:4519) Beyond Its Promising Earnings
May 01Chugai Pharmaceutical Co., Ltd. (TSE:4519) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Apr 26Chugai Pharmaceutical Co., Ltd. (TSE:4519) Investors Are Less Pessimistic Than Expected
Mar 01Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 4519's dividend payments have been volatile in the past 10 years.
Growing Dividend: 4519's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Chugai Pharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (4519) | 1.3% |
| Market Bottom 25% (JP) | 1.8% |
| Market Top 25% (JP) | 3.8% |
| Industry Average (Pharmaceuticals) | 2.4% |
| Analyst forecast (4519) (up to 3 years) | 1.6% |
Notable Dividend: 4519's dividend (1.29%) isn’t notable compared to the bottom 25% of dividend payers in the JP market (1.8%).
High Dividend: 4519's dividend (1.29%) is low compared to the top 25% of dividend payers in the JP market (3.76%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (34.4%), 4519's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (38.6%), 4519's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/30 16:01 |
| End of Day Share Price | 2025/01/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Chugai Pharmaceutical Co., Ltd. is covered by 28 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Atsushi Seki | Barclays |
| Koichi Mamegano | BofA Global Research |
| Siti Bte Salikin | CFRA Equity Research |